Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-830P is a pseudogene of the U6 small nuclear RNA gene family. U6 snRNA is an essential non-coding component of the spliceosome, facilitating the splicing of pre-mRNA by participating in catalytic activities at the spliceosome core[1][3]. Pseudogenes like RNU6-830P are the result of gene duplication or retrotransposition events, resulting in sequences that resemble functional genes but lack the capacity to produce functional RNA or protein products[5]. There is no evidence that RNU6-830P is translated, participates in cellular regulation, or is involved in any disease mechanism. As a pseudogene, it is not considered a therapeutic target, does not interact with drugs, and is not a biomarker or safety concern[5]. There is no indication in the available evidence that it is misspelled, but as a pseudogene, it lacks known biological, therapeutic, or diagnostic relevance. The information for this specific pseudogene subtype (830) is limited; most referenced research describes the general properties of U6 snRNA pseudogenes rather than RNU6-830P specifically[5]. If you are searching for a functional RNA or therapeutic target, RNU6-830P should not be considered appropriate. If more information becomes available in primary genome annotation sources, that may change, but as of now, its status is "pseudogene—non-functional"[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 830, pseudogene (RNU6-830P).